FDA announces project to advance diagnostics, approves new intubation/ventilation drug

Jun 18, 2020 - 03:23 PM
FDA-guidance

The Food and Drug Administration today announced a public-private partnership to advance COVID-19 diagnostics.

“While there are current studies of viral diagnostic and antibody tests using traditional assessment methods, the Diagnostics Evidence Accelerator will allow the community to analyze both diagnostic and clinical data in real time, which has the potential to contribute to the scientific evaluation of diagnostic tools and medical interventions for COVID-19,” said FDA Principal Deputy Commissioner Amy Abernethy, M.D.

The project is a companion to a Therapeutic Evidence Accelerator launched by the Udall Foundation for the FDA and Friends of Cancer Research in April, which brings together experts in health data aggregation and analytics to inform the collective COVID-19 response.

In other COVID-19 news this week, FDA approved a new drug to facilitate tracheal intubation and muscle relaxation during surgery or mechanical ventilation; and issued warning letters to three companies for marketing unauthorized test kits directly to consumers for at-home use.

Related News Articles

Blog
RAND 5.0 – The Health Policy Equivalent of Groundhog Day
The RAND Corporation recently released the fifth iteration of its biannual hospital price report. The AHA has previously highlighted significant flaws with…
Headline
CDC encourages older adults to get additional COVID-19 vaccine dose 
Adults age 65 and older are encouraged to receive an updated dosage of the COVID-19 vaccine, the Centers for Disease Control and Prevention announced April 25…
Headline
NASEM releases evidence review on COVID-19 vaccine safety
The Pfizer and Moderna COVID-19 vaccines can cause myocarditis, but do not appear to cause infertility, Guillain-Barré syndrome, Bell’s palsy, thrombosis with…
Headline
FDA approves combo test for flu, COVID-19; alerts providers to medical device risks 
The Food and Drug Administration recently granted emergency use authorization for the first over-the-counter home antigen test to detect both flu and COVID-19…
Headline
CDC recommends additional dose of updated COVID-19 vaccine for older adults
Centers for Disease Control and Prevention Director Mandy Cohen, M.D., Feb. 28 endorsed a recommendation by its Advisory Committee on Immunization Practices…
Headline
FDA: Paxlovid no longer labeled for emergency use after March 8
Paxlovid may no longer be distributed with an emergency use label after March 8, the Food and Drug Administration announced. Providers may dispense unexpired…